Status:
COMPLETED
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
Brief Summary
This study is conducted in Europe. The aim of this study is to investigate Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in daily Practice.
Eligibility Criteria
Inclusion
- Subjects of age above 18 years as per Victoza® SmPC par.4.2 and 5.1 diagnosed with type 2 diabetes receiving the first prescription of liraglutide in 2011
Exclusion
- None. Available data from all eligible patients for each center, will be included
Key Trial Info
Start Date :
March 26 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 16 2015
Estimated Enrollment :
1788 Patients enrolled
Trial Details
Trial ID
NCT02255266
Start Date
March 26 2015
End Date
November 16 2015
Last Update
April 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Rome, Italy, 00144